<?xml version='1.0' encoding='utf-8'?>
<document id="21941058"><sentence text="A study of drug-drug interactions in cancer patients of a south Indian tertiary care teaching hospital." /><sentence text="Drug interactions in oncology are of particular importance owing to the narrow therapeutic index and the inherent toxicity of anticancer agents" /><sentence text=" Interactions with other medications can cause small change in pharmacokinetics or pharmacodynamics of chemotherapeutic agents that could significantly alter their safety and efficacy" /><sentence text="" /><sentence text="To identify and document the potential drug-drug interactions in prescriptions of patients receiving cancer chemotherapy" /><sentence text=" Settings and Design : A tertiary care teaching hospital based prospective study" /><sentence text="" /><sentence text="Patients admitted in the medical oncology wards with different types of malignancies and receiving cancer chemotherapy during the period of June 2009 to November 2009 were included in the study" /><sentence text=" A detailed data collection was done in a specially designed proforma with ethical approval and consent of patients and their prescriptions were subjected to drug-drug interaction screening using Drug Interaction Fact Software Version-4 and standard references" /><sentence text=" Incidence of drug-drug interactions, their types, correlation between age, cancer type, number of drugs prescribed and incidence of drug interactions were analyzed" /><sentence text="" /><sentence text="Logistic regression analysis and Odds ratio were performed to identify the incidence of drug-drug interactions and their correlation with the factors above mentioned" /><sentence text="" /><sentence text="A total of 75 patients (32 males and 43 females; median age 56 years, age range 23-74) were enrolled in the study and their prescriptions were screened" /><sentence text=" 213 interactions were identified of which, 21 were major, 121 were moderate and 71 were minor" /><sentence text=" There were 13 (6" /><sentence text="1%) clinically significant interactions between anticancer drugs and 14 (6" /><sentence text="5%) drug-drug interactions between anticancer drugs and other drugs prescribed for co-morbidities" /><sentence text=" There was a positive correlation between number of drugs prescribed and drug interactions (P=0" /><sentence text="011; OR 0" /><sentence text="903)" /><sentence text="" /><sentence text="Though there was not any life threatening interactions, the potential interactions were brought to the oncologist purview for ensuring patients safety and to avoid undesirable effects" /><sentence text="" /></document>